Ensign Peak Advisors
AMAG

Ensign Peak Advisors’s AMAG Pharmaceuticals AMAG Stock Holding History

Ensign Peak Advisors’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-55,883
Closed -$525K – 1904
2020
Q3 		$525K Hold
55,883
– – ﹤0.01% 1519
2020
Q2 		$428K Hold
55,883
– – ﹤0.01% 1488
2020
Q1 		$345K Hold
55,883
– – ﹤0.01% 1462
2019
Q4 		$680K Buy
+55,883
New +$611K ﹤0.01% 1468

Ensign Peak Advisors's AMAG Position: Q4 2020 in Review

Ensign Peak Advisors sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 55,883 shares — an estimated $525K sold.

Ensign Peak Advisors first reported a position in AMAG in Q4 2019 and held it in 4 quarters. The position peaked at $680K in Q4 2019. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Ensign Peak Advisors reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Ensign Peak Advisors sold 55,883 AMAG Pharmaceuticals shares in Q4 2020, an estimated $525K.
  • Ensign Peak Advisors first reported a position in AMAG Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Ensign Peak Advisors's AMAG Pharmaceuticals position peaked at $680K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Ensign Peak Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.